BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Monday, May 6, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Aug. 21, 2017
View Archived Issues
SFX-01 protects against gait anomalies in the spontaneous STR/Ort model of osteoarthritis
Read More
VAX-DC/MM immunotherapy shows disease stabilizing activity in heavily pretreated multiple myeloma
Read More
D-512 demonstrates superior antiparkinsonian efficacy to ropinirole in rat model
Read More
Pharmacological inhibition of NOX4 as a promising new approach in cancer therapy
Read More
Ritter Pharmaceuticals discloses phase III plans regarding RP-G28
Read More
Champions Oncology to develop patient-derived xenograft models with ALCMI
Read More
Nortis receives NIH phase II SBIR fast track grant
Read More
Celgene's CC-671, a dual TTK/CLK2 inhibitor for the treatment of triple negative breast cancer
Read More
Exclusive license to fully human PD-1 antibody GLS-010 is granted to Arcus Biosciences
Read More
Toray Industries divulges novel nuclear receptor ROR-gamma antagonists
Read More
Novel excitatory amino acid transporter 3 inhibitors discovered at Roche
Read More
Shanghai Fochon Pharmaceutical, Fochon Pharma patent CDK4 and CDK6 inhibitors
Read More
Patient recruitment underway in phase II trial of SK-1405 in subjects with uremic pruritus
Read More
MacroGenics starts enrollment in first-in-human trial of MGD-013
Read More
Novartis and MMV launch phase IIb trial of antimalarial KAF-156 in adults and children
Read More
Medix initiates phase III trial of tesofensine in obesity
Read More
Ethris, AstraZeneca and MedImmune enter collaboration for respiratory mRNA therapies
Read More
Participant enrollment underway in phase II trial of concizumab in hemophilia A and B patients
Read More
Actelion initiates phase I trial of macitentan/tadalafil fixed-dose-combination
Read More
Cormedix receives NIH research grant to develop advanced antimicrobial hydrogels
Read More
JDRF enters collaboration with IBM to identify risk factors for type 1 diabetes in children
Read More
Bristol-Myers Squibb enrolls participants in phase Ib/II trial of BMS-813160
Read More